SEMINAR & VISITING SPEAKER SERIES    

DATE:    Friday, October 27th, 2017  9:00am

LOCATION:    PX236/238 PsychHealth Building

S P E A K E R:
Dr. Mike Jackson

Program Coordinator, Central Animal Core

Imaging and Transgenic Facilities - Small

Animal and Materials Imaging Core Facility

University of Manitoba

Topic:  An Introduction to the Small Animal and Materials Imaging Core Facility

BIO:  Dr. Mike Jackson obtained his BSc in Physiology from the University of Manchester, his MSc in Instrumentation and Analytical Science from the University of Manchester Institute for Science and Technology and his PhD from the Department of Protein and Molecular Biology, Royal Free Hospital School of Medicine, University of London. After completing his PhD Mike Joined the National Research Council Canada in Ottawa, applying physical techniques to the structure and interaction of biological materials. Mike was one of the initial 15 scientist transfer from Ottawa to Winnipeg to establish the NRC Institute for Biodiagnostics where he began working on novel disease diagnosis techniques, including  developing optical imaging methods for cancer diagnosis  and imaging techniques to study the link between infection and chronic disease. After almost 18 years at the NRC Mike left to pursue other opportunities, leading to his current position as Program Coordinator for the University of Manitoba’s Small Animal and Materials Imaging Core Facility.

For more information:

T: 2 0 4 - 2 3 5 - 3 9 3 9

E : Networking@manitobaneuroscience.ca

Kelly Jorundson
Coordinator, Membership & Operations
Manitoba Neuroscience Network

Email:  kjorund@sbrc.ca
Tel: 204.235.3939 
Fax: 204.237.4092

St. Boniface Hospital Albrechtsen Research Centre
Room R4046 - 351 Taché  Avenue,  Winnipeg, MB  R2H 2A6  CANADA

This email and any attachments may contain confidential, personal and/or privileged information intended for a specific individual and purpose.  If you are not the intended recipient, you are hereby notified that any disclosure, copying, retaining, distribution, access, use or modification of the contents of this e-mailed information is strictly prohibited.  If you receive this communication in error, please notify the sender immediately and delete or destroy the email message and any attachments or copies.
******************************************